Free Trial

National Bank Financial Cuts Earnings Estimates for Vitalhub

Vitalhub logo with Medical background

Key Points

  • National Bank Financial has lowered its FY2025 earnings per share (EPS) estimate for Vitalhub from $0.16 to $0.13, while maintaining a "Strong-Buy" rating on the stock.
  • Multiple analysts have raised their target prices for Vitalhub, with TD Securities setting a new target of C$16.00 and Scotiabank adjusting theirs to C$14.50.
  • Vitalhub shares opened at C$13.51 with a market capitalization of C$730.79 million, experiencing a 52-week high of C$14.64 and a low of C$7.62.
  • Need better tools to track Vitalhub? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Vitalhub Corp. (TSE:VHI - Free Report) - Research analysts at National Bank Financial cut their FY2025 EPS estimates for Vitalhub in a note issued to investors on Monday, August 11th. National Bank Financial analyst J. Shao now anticipates that the company will earn $0.13 per share for the year, down from their prior forecast of $0.16. National Bank Financial has a "Strong-Buy" rating on the stock. The consensus estimate for Vitalhub's current full-year earnings is $0.23 per share. National Bank Financial also issued estimates for Vitalhub's Q4 2025 earnings at $0.03 EPS, FY2026 earnings at $0.18 EPS and FY2027 earnings at $0.29 EPS.

A number of other equities analysts also recently issued reports on VHI. TD Securities increased their price objective on Vitalhub from C$15.00 to C$16.00 and gave the stock a "buy" rating in a report on Monday. National Bankshares set a C$14.00 target price on shares of Vitalhub and gave the stock an "outperform" rating in a research report on Tuesday, June 10th. Raymond James Financial lifted their price target on shares of Vitalhub from C$14.50 to C$15.00 and gave the company an "outperform" rating in a research report on Tuesday. Finally, Scotiabank raised their target price on shares of Vitalhub from C$14.00 to C$14.50 and gave the company an "outperform" rating in a research note on Friday, June 20th. Six research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Vitalhub has an average rating of "Buy" and an average target price of C$13.75.

Read Our Latest Analysis on VHI

Vitalhub Stock Performance

Shares of TSE:VHI opened at C$13.51 on Wednesday. The firm has a market capitalization of C$730.79 million, a P/E ratio of 219.74, a P/E/G ratio of 1.18 and a beta of 1.26. The stock has a 50 day moving average price of C$11.97 and a 200-day moving average price of C$10.89. Vitalhub has a 52-week low of C$7.62 and a 52-week high of C$14.64.

Insider Buying and Selling at Vitalhub

In related news, Director Francis Nelson Shen bought 25,000 shares of the company's stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average price of C$10.23 per share, for a total transaction of C$255,750.00. 18.57% of the stock is owned by insiders.

About Vitalhub

(Get Free Report)

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.

See Also

Earnings History and Estimates for Vitalhub (TSE:VHI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Vitalhub Right Now?

Before you consider Vitalhub, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.

While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom
3 Growth Stock Winners to Watch And 3 to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines